DMXAA (Vadimezan, ASA404) is a multi-kinase inhibitor targeting VEGFR2 in particular.
| Image |  |
|---|---|
| Description | scientific article published in May 2012 |
| Author/s |
author: Jonathan W. Astin Philip Crosier |
| Publication date | May 1, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |